Artivion, Inc. (AORT)
USD 27.79
(-3.84%)
USD 27.79
(-3.84%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -30.69 Million USD | -59.27% |
| 2022 | -19.19 Million USD | -29.38% |
| 2021 | -14.83 Million USD | 11.08% |
| 2020 | -16.68 Million USD | -1069.88% |
| 2019 | 1.72 Million USD | 145.2% |
| 2018 | -3.8 Million USD | -202.73% |
| 2017 | 3.7 Million USD | -65.63% |
| 2016 | 10.77 Million USD | 169.11% |
| 2015 | 4 Million USD | -45.3% |
| 2014 | 7.32 Million USD | -54.72% |
| 2013 | 16.17 Million USD | 103.52% |
| 2012 | 7.94 Million USD | 7.8% |
| 2011 | 7.37 Million USD | 86.89% |
| 2010 | 3.94 Million USD | -54.56% |
| 2009 | 8.67 Million USD | -73.63% |
| 2008 | 32.9 Million USD | 356.99% |
| 2007 | 7.2 Million USD | 1872.88% |
| 2006 | 365 Thousand USD | 101.87% |
| 2005 | -19.53 Million USD | -4.19% |
| 2004 | -18.74 Million USD | 41.94% |
| 2003 | -32.29 Million USD | -16.33% |
| 2002 | -27.76 Million USD | -402.87% |
| 2001 | 9.16 Million USD | 17.26% |
| 2000 | 7.81 Million USD | 75.62% |
| 1999 | 4.45 Million USD | -31.52% |
| 1998 | 6.5 Million USD | 38.3% |
| 1997 | 4.7 Million USD | 20.51% |
| 1996 | 3.9 Million USD | 77.27% |
| 1995 | 2.2 Million USD | 69.23% |
| 1994 | 1.3 Million USD | 116.67% |
| 1993 | 600 Thousand USD | -14.29% |
| 1992 | 700 Thousand USD | 200.0% |
| 1991 | -700 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 7.53 Million USD | 289.51% |
| 2024 Q2 | -2.11 Million USD | -128.1% |
| 2023 Q2 | -3.38 Million USD | 75.01% |
| 2023 Q4 | -3.97 Million USD | 59.44% |
| 2023 FY | -30.56 Million USD | -59.27% |
| 2023 Q1 | -13.53 Million USD | -723.88% |
| 2023 Q3 | -9.8 Million USD | -189.8% |
| 2022 FY | -19.19 Million USD | -29.38% |
| 2022 Q1 | -3.38 Million USD | 83.14% |
| 2022 Q2 | -4.25 Million USD | -25.67% |
| 2022 Q3 | -13.71 Million USD | -221.98% |
| 2022 Q4 | 2.16 Million USD | 115.82% |
| 2021 Q1 | -3.13 Million USD | 9.25% |
| 2021 Q2 | -2.17 Million USD | 30.59% |
| 2021 Q3 | 10.58 Million USD | 585.86% |
| 2021 Q4 | -20.1 Million USD | -289.95% |
| 2021 FY | -14.83 Million USD | 11.08% |
| 2020 FY | -16.68 Million USD | -1069.88% |
| 2020 Q3 | -2.87 Million USD | 22.2% |
| 2020 Q1 | -6.66 Million USD | -878.71% |
| 2020 Q2 | -3.68 Million USD | 44.65% |
| 2020 Q4 | -3.45 Million USD | -20.49% |
| 2019 Q2 | 2.83 Million USD | 1053.54% |
| 2019 FY | 1.72 Million USD | 145.2% |
| 2019 Q1 | -297 Thousand USD | 82.94% |
| 2019 Q3 | -134 Thousand USD | -104.73% |
| 2019 Q4 | -681 Thousand USD | -408.21% |
| 2018 Q2 | 226 Thousand USD | 105.86% |
| 2018 Q4 | -1.74 Million USD | -211.25% |
| 2018 Q3 | 1.56 Million USD | 592.48% |
| 2018 FY | -3.8 Million USD | -202.73% |
| 2018 Q1 | -3.85 Million USD | -28.2% |
| 2017 Q4 | -3 Million USD | -326.94% |
| 2017 Q3 | 1.32 Million USD | -58.11% |
| 2017 FY | 3.7 Million USD | -65.63% |
| 2017 Q2 | 3.16 Million USD | 42.29% |
| 2017 Q1 | 2.22 Million USD | -23.27% |
| 2016 Q2 | 2.34 Million USD | -7.63% |
| 2016 FY | 10.77 Million USD | 169.11% |
| 2016 Q1 | 2.54 Million USD | -3.6% |
| 2016 Q4 | 2.89 Million USD | -3.21% |
| 2016 Q3 | 2.99 Million USD | 27.52% |
| 2015 Q3 | 2.14 Million USD | 527.29% |
| 2015 Q2 | -502 Thousand USD | -83.21% |
| 2015 Q4 | 2.63 Million USD | 22.89% |
| 2015 FY | 4 Million USD | -45.3% |
| 2015 Q1 | -274 Thousand USD | -115.43% |
| 2014 Q4 | 1.77 Million USD | -23.65% |
| 2014 Q3 | 2.32 Million USD | 7.64% |
| 2014 Q1 | 1.05 Million USD | -88.27% |
| 2014 Q2 | 2.16 Million USD | 104.06% |
| 2014 FY | 7.32 Million USD | -54.72% |
| 2013 Q1 | 2.19 Million USD | 5.23% |
| 2013 Q2 | 1.78 Million USD | -18.57% |
| 2013 FY | 16.17 Million USD | 103.52% |
| 2013 Q4 | 9.02 Million USD | 184.82% |
| 2013 Q3 | 3.16 Million USD | 77.54% |
| 2012 Q4 | 2.08 Million USD | 35.44% |
| 2012 Q3 | 1.53 Million USD | -53.87% |
| 2012 Q2 | 3.33 Million USD | 236.43% |
| 2012 Q1 | 991 Thousand USD | -46.89% |
| 2012 FY | 7.94 Million USD | 7.8% |
| 2011 Q1 | 1.66 Million USD | -21.23% |
| 2011 Q4 | 1.86 Million USD | -7.58% |
| 2011 Q2 | 1.82 Million USD | 9.24% |
| 2011 Q3 | 2.01 Million USD | 10.93% |
| 2011 FY | 7.37 Million USD | 86.89% |
| 2010 Q4 | 2.11 Million USD | 169.78% |
| 2010 Q1 | 1.93 Million USD | -18.26% |
| 2010 Q2 | 2.92 Million USD | 51.29% |
| 2010 Q3 | -3.03 Million USD | -203.59% |
| 2010 FY | 3.94 Million USD | -54.56% |
| 2009 Q1 | 1.94 Million USD | -91.41% |
| 2009 Q3 | 1.86 Million USD | 74320.46% |
| 2009 FY | 8.67 Million USD | -73.63% |
| 2009 Q4 | 2.36 Million USD | 27.07% |
| 2009 Q2 | 2502.00 USD | -99.87% |
| 2008 Q3 | 3.55 Million USD | -8.54% |
| 2008 Q1 | 2.76 Million USD | 4.38% |
| 2008 FY | 32.9 Million USD | 356.99% |
| 2008 Q2 | 3.88 Million USD | 40.61% |
| 2008 Q4 | 22.69 Million USD | 538.33% |
| 2007 FY | 7.2 Million USD | 1872.88% |
| 2007 Q4 | 2.64 Million USD | 38.91% |
| 2007 Q3 | 1.9 Million USD | 47.71% |
| 2007 Q2 | 1.29 Million USD | -4.65% |
| 2007 Q1 | 1.35 Million USD | 2808.0% |
| 2006 FY | 365 Thousand USD | 101.87% |
| 2006 Q4 | -50 Thousand USD | -102.53% |
| 2006 Q3 | 1.97 Million USD | 811.52% |
| 2006 Q2 | 217 Thousand USD | 112.19% |
| 2006 Q1 | -1.78 Million USD | -161.38% |
| 2005 FY | -19.53 Million USD | -4.19% |
| 2005 Q1 | -1.35 Million USD | 42.57% |
| 2005 Q3 | -3.11 Million USD | 78.32% |
| 2005 Q4 | -681 Thousand USD | 78.16% |
| 2005 Q2 | -14.37 Million USD | -959.62% |
| 2004 Q4 | -2.36 Million USD | 60.67% |
| 2004 Q2 | -3.35 Million USD | 52.29% |
| 2004 Q1 | -7.02 Million USD | 3.01% |
| 2004 FY | -18.74 Million USD | 41.94% |
| 2004 Q3 | -6 Million USD | -79.24% |
| 2003 FY | -32.29 Million USD | -16.33% |
| 2003 Q4 | -7.24 Million USD | -54.29% |
| 2003 Q3 | -4.69 Million USD | 78.99% |
| 2003 Q1 | -434 Thousand USD | 92.38% |
| 2003 Q2 | -22.34 Million USD | -5048.85% |
| 2002 Q4 | -5.69 Million USD | 71.0% |
| 2002 Q3 | -19.64 Million USD | -255.78% |
| 2002 Q2 | -5.52 Million USD | -277.9% |
| 2002 Q1 | 3.1 Million USD | 113.19% |
| 2002 FY | -27.76 Million USD | -402.87% |
| 2001 Q1 | 2.47 Million USD | 28.59% |
| 2001 FY | 9.16 Million USD | 17.26% |
| 2001 Q4 | 1.45 Million USD | -45.91% |
| 2001 Q3 | 2.69 Million USD | 5.98% |
| 2001 Q2 | 2.54 Million USD | 2.5% |
| 2000 FY | 7.81 Million USD | 75.62% |
| 2000 Q4 | 1.92 Million USD | -16.51% |
| 2000 Q1 | 1.6 Million USD | 559.6% |
| 2000 Q2 | 1.97 Million USD | 23.38% |
| 2000 Q3 | 2.3 Million USD | 16.62% |
| 1999 Q2 | 1.7 Million USD | 21.43% |
| 1999 Q1 | 1.4 Million USD | 0.0% |
| 1999 Q4 | -349 Thousand USD | -120.53% |
| 1999 Q3 | 1.7 Million USD | 0.0% |
| 1999 FY | 4.45 Million USD | -31.52% |
| 1998 FY | 6.5 Million USD | 38.3% |
| 1998 Q1 | 1.2 Million USD | 9.09% |
| 1998 Q2 | 2 Million USD | 66.67% |
| 1998 Q3 | 1.9 Million USD | -5.0% |
| 1998 Q4 | 1.4 Million USD | -26.32% |
| 1997 Q1 | 1 Million USD | 11.11% |
| 1997 FY | 4.7 Million USD | 20.51% |
| 1997 Q3 | 1.5 Million USD | 25.0% |
| 1997 Q4 | 1.1 Million USD | -26.67% |
| 1997 Q2 | 1.2 Million USD | 20.0% |
| 1996 Q4 | 900 Thousand USD | -30.77% |
| 1996 Q3 | 1.3 Million USD | 30.0% |
| 1996 Q2 | 1 Million USD | 25.0% |
| 1996 Q1 | 800 Thousand USD | 33.33% |
| 1996 FY | 3.9 Million USD | 77.27% |
| 1995 Q2 | 600 Thousand USD | 50.0% |
| 1995 Q3 | 700 Thousand USD | 16.67% |
| 1995 Q4 | 600 Thousand USD | -14.29% |
| 1995 FY | 2.2 Million USD | 69.23% |
| 1995 Q1 | 400 Thousand USD | -20.0% |
| 1994 Q2 | 300 Thousand USD | 50.0% |
| 1994 Q4 | 500 Thousand USD | 66.67% |
| 1994 FY | 1.3 Million USD | 116.67% |
| 1994 Q1 | 200 Thousand USD | 0.0% |
| 1994 Q3 | 300 Thousand USD | 0.0% |
| 1993 Q2 | 200 Thousand USD | 100.0% |
| 1993 FY | 600 Thousand USD | -14.29% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q3 | 100 Thousand USD | -50.0% |
| 1993 Q4 | 200 Thousand USD | 100.0% |
| 1992 FY | 700 Thousand USD | 200.0% |
| 1992 Q1 | -100 Thousand USD | 0.0% |
| 1992 Q3 | - USD | -100.0% |
| 1992 Q2 | 600 Thousand USD | 700.0% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1991 Q1 | -100 Thousand USD | 0.0% |
| 1991 Q2 | -400 Thousand USD | -300.0% |
| 1991 Q3 | -100 Thousand USD | 75.0% |
| 1991 Q4 | -100 Thousand USD | 0.0% |
| 1991 FY | -700 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 100.536% |
| Allurion Technologies Inc. | -82.3 Million USD | 62.711% |
| Avanos Medical, Inc. | -61.8 Million USD | 50.34% |
| Butterfly Network, Inc. | -133.69 Million USD | 77.046% |
| Butterfly Network, Inc. | -133.69 Million USD | 77.046% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 95.185% |
| Boston Scientific Corporation | 1.59 Billion USD | 101.927% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -109.202% |
| CONMED Corporation | 64.45 Million USD | 147.612% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 102.188% |
| Paragon 28, Inc. | -47.84 Million USD | 35.85% |
| Glaukos Corporation | -134.66 Million USD | 77.209% |
| Globus Medical, Inc. | 122.87 Million USD | 124.977% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | -45.086% |
| Integer Holdings Corporation | 90.65 Million USD | 133.855% |
| Medtronic plc | 3.67 Billion USD | 100.835% |
| Nevro Corp. | -92.21 Million USD | 66.718% |
| Owlet, Inc. | -32.9 Million USD | 6.72% |
| Penumbra, Inc. | 90.95 Million USD | 133.742% |
| Vicarious Surgical Inc. | -71.07 Million USD | 56.818% |
| Smith & Nephew plc | 263 Million USD | 111.669% |
| Sonendo, Inc. | -60.91 Million USD | 49.622% |
| STERIS plc | 378.23 Million USD | 108.114% |
| Stryker Corporation | 3.16 Billion USD | 100.97% |
| Vapotherm, Inc. | -58.19 Million USD | 47.262% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 102.997% |